Developing a proprietary hydrogen peroxide treatment for common skin lesions.

Aclaris Therapeutics Inc

Aclaris Therapeutics, Inc. is a clinical-stage specialty pharmaceutical company, which engages in identifying, developing and commercializing novel drugs to address unmet needs in dermatology. It also pursues the development of topical agents for the treatment and prevention of a number of medical and cosmetic indications. The company was founded by Neal S. Walker, Frank Ruffo, Kamil Ali-Jackson, Christopher V. Powala and Stuart D. Shanler in July 2012 and is headquartered in Malvern, PA.

Should you buy, sell, or hold Aclaris Therapeutics Inc (ACRS) ?

Aclaris Therapeutics Inc (ACRS) : Buy or Sell